Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Amphastar Pharmaceuticals Inc
About AMPH
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells active pharmaceutical ingredient (API) products. Most of the Company's finished products are contracted and distributed through group purchasing organizations, drug wholesalers, and drug retailers. The Company manufactures and sells over 25 prescription pharmaceutical products, and one over-the-counter product, Primatene MIST. Its marketed products include BAQSIMI (glucagon) nasal powder 3mg, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone, Cortrosyn, Amphadase, and Epinephrine injection. It manufactures and sells two API products: Recombinant Human Insulin (RHI API) and porcine insulin API. It is also focused on generic and proprietary product candidates in the injectable, inhalable, topical, and intranasal markets.
Find out what a historical investment in Amphastar Pharmaceuticals Inc would be worth today using our AMPH stock calculator.
Market Capitalisation
$743.85M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
679.29K
High today
$17.53
Low today
$16.76
Open price
$17.27
52-week high
$31.26
52-week low
$17.03
Ready to start your investing journey with Stake?
Open an accountHow do I buy AMPH shares in Australia?
Buying AMPH shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Amphastar Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AMPH
What is the ticker symbol of Amphastar Pharmaceuticals Inc?
The ticker symbol for Amphastar Pharmaceuticals Inc is AMPH.
How much is one share of AMPH?
One share of AMPH is valued at $16.83 as of 16 May 2026.
What is the market capitalisation of Amphastar Pharmaceuticals Inc AMPH?
As of 16 May 2026 Amphastar Pharmaceuticals Inc has a market cap of $743.85M.
What is the P/E ratio of AMPH?
The Price to Earnings ratio of AMPH is 10.37.
What is the Earnings Per Share of AMPH?
The Earnings Per Share of AMPH is $1.67.
What is the 52-week high for Amphastar Pharmaceuticals Inc stock?
The Amphastar Pharmaceuticals Inc 52-week high stock price is $31.26.
What is the 52-week low for Amphastar Pharmaceuticals Inc stock?
The Amphastar Pharmaceuticals Inc 52-week low stock price is $17.03.
Can I buy AMPH shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AMPH shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AMPH on Stake
- Buy AMPH from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AMPH from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AMPH related stocks